These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12957094)

  • 21. An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination.
    Kolavic SA; Kimura A; Simons SL; Slutsker L; Barth S; Haley CE
    JAMA; 1997 Aug; 278(5):396-8. PubMed ID: 9244331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shigella isolates of Nepal: changes in the incidence of shigella subgroups and trends of antimicrobial susceptibility pattern.
    Kansakar P; Malla S; Ghimire GR
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):32-7. PubMed ID: 18603983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Short-term ciprofloxacin treatment of bacillary dysentery due to Shigella dysenteriae type 1 in Rwandan refugees].
    Soares JL; Arendt V; Coue JC; Milleliri JM; Philips B; Regis R; Mérouze F; Rey JL
    Med Trop (Mars); 1994; 54(4):319-23. PubMed ID: 7746123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using European travellers as an early alert to detect emerging pathogens in countries with limited laboratory resources.
    Guerin PJ; Grais RF; Rottingen JA; Valleron AJ;
    BMC Public Health; 2007 Jan; 7():8. PubMed ID: 17239228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outbreak of dysentery due to nalidixic acid resistant S. dysenteriae 1 at Agartala, Tripura: a hospital based study.
    Datta P; Sen D
    Indian J Public Health; 1990; 34(1):11-4. PubMed ID: 2101382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and phenotypic characterization of potentially new Shigella dysenteriae serotype.
    Coimbra RS; Lenormand P; Grimont F; Bouvet P; Matsushita S; Grimont PA
    J Clin Microbiol; 2001 Feb; 39(2):618-21. PubMed ID: 11158117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial enteric pathogens in children with acute dysentery in Thailand: increasing importance of quinolone-resistant Campylobacter.
    Bodhidatta L; Vithayasai N; Eimpokalarp B; Pitarangsi C; Serichantalergs O; Isenbarger DW
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):752-7. PubMed ID: 12757222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiologic investigation of an outbreak of Shiga bacillus dysentery in an island population.
    Khan M; Rahaman MM; Aziz KM; Islam S
    Southeast Asian J Trop Med Public Health; 1975 Jun; 6(2):251-6. PubMed ID: 1101385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
    Salam MA; Dhar U; Khan WA; Bennish ML
    Lancet; 1998 Aug; 352(9127):522-7. PubMed ID: 9716056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-dose treatment with pefloxacin for infection due to multidrug-resistant Shigella dysenteriae type 1 in Burundi.
    Gendrel D; Moreno JL; Nduwimana M; Baribwira C; Raymond J
    Clin Infect Dis; 1997 Jan; 24(1):83. PubMed ID: 8994771
    [No Abstract]   [Full Text] [Related]  

  • 31. Shigellosis in Mozambique: the 1993 outbreak rehabilitation--a follow-up study.
    Aragón M; Barreto A; Chambule J; Noya A; Tallarico M
    Trop Doct; 1995 Oct; 25(4):159-62. PubMed ID: 7502323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children.
    Zimbabwe, Bangladesh, South Africa (Zimbasa) Dysentery Study Group
    Pediatr Infect Dis J; 2002 Dec; 21(12):1136-41. PubMed ID: 12488664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using epidemiologic tools to control an outbreak of diarrhoea in a textile factory, Bulawayo, Zimbabwe.
    Tshimanga M; Peterson DE; Dlodlo RA
    East Afr Med J; 1997 Nov; 74(11):719-22. PubMed ID: 9557445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones.
    Sarkar K; Ghosh S; Niyogi SK; Bhattacharya SK
    Lancet; 2003 Mar; 361(9359):785. PubMed ID: 12620764
    [No Abstract]   [Full Text] [Related]  

  • 35. Short-term pefloxacin therapy in Madagascan children with shigellosis due to multiresistant organisms.
    Guyon P; Cassel-Beraud AM; Rakotonirina G; Gendrel D
    Clin Infect Dis; 1994 Dec; 19(6):1172-3. PubMed ID: 7888566
    [No Abstract]   [Full Text] [Related]  

  • 36. Predictors of mortality in children hospitalized with dysentery in Harare, Zimbabwe.
    Nathoo KJ; Porteous JE; Siziya S; Wellington M; Mason E
    Cent Afr J Med; 1998 Nov; 44(11):272-6. PubMed ID: 10910572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shigella dysenteriae type 1--Guatemala, 1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Jun; 40(25):421, 427-8. PubMed ID: 2046650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical presentation of shigellosis during the 1984 epidemic of bacillary dysentery in West Bengal.
    Dutta P; Bhattacharya SK; Dutta D; Sen D; Saha MR; Nair GB; Bhattacharya MK; Bose R
    J Assoc Physicians India; 1987 Mar; 35(3):195-7. PubMed ID: 3301795
    [No Abstract]   [Full Text] [Related]  

  • 39. Haemolytic uraemic syndrome during shigellosis.
    Butler T
    Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):395-9. PubMed ID: 22579556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nalidixic acid-resistant Shigella dysenteriae type I in KwaZulu-Natal.
    Karas JA; Pillay DG
    S Afr Med J; 1996 Jan; 86(1):93. PubMed ID: 8685796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.